Clinical pathogens especially Gram-negative bacteria developing resistance to thirdgeneration cephalosporins are making the clinical outcome more complicated and serious. This study was undertaken to evaluate the distribution of extended-spectrum beta-lactamases in Tamil Nadu regions in India. For this study, clinical samples were collected from five different hospitals located in Tamil Nadu and ESBL producing Gram-negative isolates were characterized. Minimal inhibitory concentration (MIC) was performed using cefotaxime and ceftazidime. The bla ESBL producing genes were screened using multiplex PCR for the genes, CTX-M group-1,-2,-8,-9,-26. Conjugation studies were performed using E. coli AB1157 as a recipient for the isolates harboring plasmid-borne resistance following broth-mating experiment. In total, 1500 samples were collected and 599 Gram-negative bacteria were isolated that included Escherichia coli (n=233), Klebsiella pneumoniae (n=182), Pseudomonas aeruginosa (n=79), Citrobacter spp. (n=30), Proteus mirabilis (n=28), Salmonella spp. (n=21), Acinetobacter baumannii (n=12), Serratia spp. (n=6), Shigella spp. (n=4), Morganella morganii (n=3) and Providencia spp. (n=1). MIC results showed that 358 isolates were resistant to cefotaxime and ceftazidime. Further, ESBL gene amplification results showed that 19 isolates had CTX-M group-1 gene including E. coli (n=16), K. pneumoniae (n=2) and P. aeruginosa (n=1) whereas one M. morganii isolate had CTX-M group-9 gene in their plasmid. Through conjugation studies, 12/20 isolates were found to be involved in the transformation of its plasmid-borne resistance gene. Our study highlighted the role of horizontal gene transfer in the dissemination of plasmid-borne bla CTX-M resistance genes among ESBL producing isolates.
INTRODUCTION
The arousal of β-lactamase production in bacteria provoked the emergence of beta-lactam resistance. Beta-lactamase is an enzyme which actively participates in the hydrolysis of βlactam antibiotics; as a consequence, it loses its antibacterial activity against the pathogen [Paterson et al., 2005] . ESBL producing Gram-negative bacteria are rapidly evolving and are the up-most clinical vexation by considering the potential risk of disseminating the infection [Rawat and Nair, 2006 ]. The infections caused by such resistant bacteria are increasing over the past decade and has become a worldwide epidemic. Cephalosporin-resistant bacteria were also found to have co-resistance to other antibiotics such as tetracyclines, sulfonamides and aminoglycosides posing serious therapeutic challenge [Cantón and Coque, 2006 ]. Among the β-lactam antibiotics, the third generation cephalosporin plays a vital role in treating serious infections caused by Gram-negative bacteria [Paterson, 2006] . The antibacterial activity of cephalosporin group of antibiotics was inhibited greatly by the production of ESBLs. In Enterobacteriaceae family, E. coli and K. pneumoniae were confessed as major ESBL producing organism [Livermore et al., 2007] . This enzyme was also effectively produced by other members of the Enterobacteriaceae and by certain non-fermenting Gramnegative bacteria [Livermore et al., 2007] . The concern towards ESBL producing Klebsiella has increased by the report from Germany revealed that there is an emergence of plasmid- pneumoniae are of great concern because of the lesser availability of last-line treatment options [Salvatore and Resman-Targoff, 2015]. CTX-M emerge as the prevalent family of ESBL, which can actively be involving in imparting resistance to advanced generations in cephalosporin group of antibiotics [Livermore, 2012] . Among the various CTX-M variants, CTX-M-15 was considered to be the more prominent and it was first reported from the Indian subcontinent [Pitout and Laupland, 2008] . The emanation of plasmid-mediated resistance and other mobile genetic elements made chances for the spread of resistance genes rapidly by horizontal gene transfer [Karim et al., 2001 ]. The mobilization of resistance genes was greatly encouraged by the various genetic elements like insertion sequences, a segment which provides switch around mechanism of resistance to the bacteria for their survival [Karim et al., 2001] . The evolution of bacteria was highly supported by horizontal gene transfer (HGT) by taking up the genes or operons from the pool of mobile genetic elements [Karim et al., 2001 ]. More studies on the prevalence of ESBL producers among nosocomial pathogens and plasmid-mediated resistance transmissibility will provide more insight into the clinical problems. Our study aimed to find out the prevalence of ESBL producers among Gramnegative bacteria isolated from clinical samples within Tamil Nadu, South India and also to reveal the role of bacterial conjugation in disseminating plasmid-borne bla CTX-M gene. 
MATERIAL AND METHODS

Clinical Samples and Study Area
Isolation and Identification of Clinical Isolates
The samples were collected in sterile containers and were cultured immediately on blood agar and characterized on MacConkey agar plates. Using standard microbiological procedures the clinically important bacteria were isolated from the respective samples. Bacterial isolation mainly focused on Enterobacteriaceae and all the isolated strains were identified at species level using automated methods, API 20E identification system (BioMerieux, Marcy, Etoile, France) and further identified using the standardized microbial identification by ID 32GN strips.
Antibiotic Susceptibility Testing
A. Disc diffusion method
Antibiotic susceptibility testing was performed for all the isolates by disc diffusion method and the results were elucidated according to CLSI guidelines. The following antibiotics were used, ampicillin (10 µg), amikacin (30 µg), gentamicin (10 µg), ciprofloxacin (30 µg), ofloxacin (5 µg), cefotaxime (30 µg), ceftazidime (30 µg), ceftriaxone (30 µg),cefpodoxime (10 µg), cefepime (30 µg), aztreonam (30 µg), imipenem (10 µg), meropenem (10 µg), piperacillin-tazobactam (100/10 µg), amoxicillin-clavulanic acid (20/10 µg) and nitrofurantoin (30 µg) (Hi-Media, India). The reference strains used for this study were E. coli ATCC -25988, K. pneumoniae ATCC -700603 and P. aeruginosa ATCC -27853. ESBL enzyme producing isolates were determined by the combination disk technique using the test inoculum of 10 5 CFU/mL. The antibiotic disks containing ceftazidime (30 µg), cefotaxime (30 µg) and cefpodoxime (10 µg) were tested alone or in combination with clavulanic acid (10 µg). That isolates that showed an increase in their inhibitory zones, when tested against ceftazidime-clavulanate, cefotaxime-clavulanate or cefpodoxime-clavulanate of at least >5mm when compared to ceftazidime, cefotaxime or cefpodoxime alone respectively, were determined to be ESBL producers.
B. Minimum Inhibitory Concentration
MIC was performed with micro-broth dilution method for ceftazidime and cefotaxime following the CLSI guidelines. In brief, two-fold serial dilutions were done by adding 100 µL of MH broth in 96 well plate and the respective antibiotics were amended with the concentration ranging from 0.25 to 256 mg/L respectively. Later, an inoculum of 10 5 CFU/ml was inoculated on the respective wells and incubated for 16 hours. For this study, K. pneumoniae ATCC700603 and E. coli ATCC25988 were used as positive and negative controls, respectively.
Molecular studies
A. DNA Isolation
DNA was obtained using a modified alkaline lysis method. Briefly, a single colony of each bacterium was inoculated from MacConkey agar into 5 mL of LB broth and incubated at 37°C for 18 h. Cells were pelleted and resuspended in 100 μL of glucose 50 mM, 25 mM tris-Cl and 10 mM EDTA (pH 8.0), and RNase was added to a final concentration of 20 μg/mL.
To the solution, 200 μl of 0.2N NaOH, 1% SDS was added. In the tubes, 150 μL of 5M potassium acetate, glacial acetic acid and water was added and stored at 4°C for 5 min and centrifuged. The supernatant was extracted with two volumes of phenol: chloroform. The nucleic acid was precipitated by adding 100% ethanol. The pellet was washed with 70% ethanol and nucleic acid was recovered by centrifugation; the DNA pellet was resuspended in sterile distilled water and stored at 4°C. The plasmid profile of each strain was observed in 0.8% of agarose gel.
B. Polymerase Chain Reaction
The amplification of genes coding for bla CTX-M was performed by PCR using the primers reported in our previous study [Ramesh et al., 2015] . Polymerase chain reaction was accomplished in 50 μL reactions, approximately 10ng of plasmid DNA as a template, reaction volume containing: 10 pmol of each primer, 200μm dNTP, 1.5mM MgCl 2 , 1X Taq buffer and 2U of Taq polymerase (Genei, Bangalore, India). All the PCR products were sequenced.
Transferability assay
To study the transferability of resistance, mating experiments were performed using plasmidfree E. coli AB1157 (Str r ) as recipient strain and all the ESBL producing E. coli as donors [Vaidya, 2011] . Overnight cultures of both donor and recipient strains grown in MH broth at 37°C were mixed together at 1:10 (v/v) proportion and incubated at 37°C for at least 4 h without shaking. Then, 0.1 mL of the mixture was spread onto the surface of MH agar plates containing streptomycin (100 mg/L) and cefotaxime (2 mg/L). The transconjugants growing on the selection plates were subjected to an ESBL screening, antibiotic susceptibility testing and PCR to confirm the possible acquisition of resistance.
Statistical analysis
Data were recorded and entered into a Graph Pad software (online) database. Analyses were performed using Chi-square test, or Fisher exact test when appropriate to compare proportions. All statistical analyses were two-sided, and significance was set at p < 0.05.
RESULTS
Isolation of Gram-negative bacteria from clinical samples
Out of 1500 samples collected during the study period, 599 (39.9%) Gram-negative bacteria were isolated ( Table 1 ). The clinical distribution of isolates includes, 346 (57.7%) from urine, 80 (13.3%) from stool, 55 (9.1%) from pus, 44 (7.3%) from blood, 31 (5.1%) from wound swab, 17 (2.8%) from sputum, 10 (1.6%) from endotracheal secretion, 4 (0.6%) from throat swab, 3 (0.5%) from bronchial wash, 2 (0.3%) from semen, 2 (0.3%) from vaginal swab, 2 
Identification of Clinical Isolates
The isolates belonged to 11 different genera of Gram-negative bacteria including E. coli (n=233, 38%), K. pneumoniae (n=182, 30%), P. aeruginosa (n=79, 13%), Citrobacter spp. and Providencia spp. (n=1, 0.1%). Among the isolates, E. coli and K. pneumoniae were the most predominant species in all the six sampling locations and the majority of the strains were obtained from urine samples followed by stool and pus. The maximum number of the aforementioned Gram-negative bacteria was isolated from the patients between the age group of 15 to 45; in addition, samples collected from females were found to encounter pathogenic Gram-negative bacteria more frequently than from the male patients.
Antibiotic Susceptibility Testing
Among the bacterial pathogens isolated from the clinical samples from various locations in Tamil Nadu, 498 (83.1%) out of 599 strains were found to be cephalosporin-resistant by disk diffusion studies. The antimicrobial sensitivity patterns showed that the overall resistance pattern for ampicillin was 87.5% followed by cefepime (82.5%), cefotaxime (79.2%), ceftriaxone (78.2%), ceftazidime (77.5%), cefpodoxime (76.5%), ofloxacin (70.8%), gentamicin (67.7%), ciprofloxacin (64.5%), amikacin (57.3%), nitrofurantoin (26.5%), piperacillin-tazobactam (21.8%), amoxicillin-clavulanic acid (21.5%), imipenem (3.9%), and meropenem (3.6%). The overall sensitivity for meropenem was 96.4%, followed by imipenem (96.1%), amoxicillin-clavulanic acid (78.5%) and piperacillin-tazobactam (78.1%). The overall prevalence of isolates resistant to cephalosporins was 84.3%, 72.3%, 81.6%, 79.4%, 95% and 80% in Chennai, Salem, Tiruchirappalli, Madurai, Tirunelveli and Coimbatore respectively. In the case of combination disk method, out of 498 isolates screened, only 358 (64.7%) isolates were positive and 140 (35.2%) isolates were negative for ESBL production ( Table 2) .
MIC was performed for those isolates that were found to be cephalosporin-resistant by disk diffusion and combination-disk methods. Of the 358 isolates screened for the MIC analysis using ceftazidime and cefotaxime, 85% of the isolates showed MIC ≥64 μg/mL. However, cefotaxime and ceftazidime resistant isolates with MIC values >256 μg/mL were 36 and 40 respectively ( Table 3 ). In total, 305 isolates were found to be cefotaxime and ceftazidime *Bacterial isolates that were found to be ESBL producer using disk-diffusion method was further studied for combination-disk method.
Plasmid profiling and multiplex PCR
From the antibiotic susceptibility studies, 40 isolates that had MIC values >256 μg/mL were selected for plasmid profiling. Out of 40 selected isolates, 28 (70%) yielded plasmids of the size ranging from 1 kb to 100 kb while the remaining were found to be plasmid-free. Multiple plasmids were seen in E. coli, K. pneumoniae and P. aeruginosa. There were some isolates that harbored six or seven plasmids of varying size, for instance, an E. coli isolated from urine sample carried seven plasmids and other E. coli had six plasmids, and K. pneumoniae with five plasmids were isolated from stool samples. Therefore, E. coli and K. pneumoniae were the most predominant that had more than two plasmids of varying size. All the isolates that had one or more plasmids were subjected to conjugation experiments.
Plasmid DNA was used to screen CTX-M group genes (1, 2, 8, 9, and 26) and our data revealed that group-1 CTX-M was predominantly found in all the sampling locations included in the study. CTX-M-group-1 which was the most prevalent ESBL gene was detected in 19
isolates (95% of ESBLs), that includes, 16 (80%) of E. coli, 2 (10%) of K. pneumoniae, 1 (5%) of P. aeruginosa and followed by group-9 in one isolate (5%), in M. morganii. More than one CTX-M beta-lactamases (Group-1, -9) were found in one E. coli strain. None of the isolates from any of the locations had shown the presence of all the five CTX-M group genes.
All the amplified CTX-M group (1 and 9) genes were sequenced and GenBank accession numbers were obtained. *Bacterial isolates that were found to be ESBL producers by earlier phenotypic studies were taken for MIC determination.
Transferability assay
From the molecular studies, 20 isolates that were found to be carrying plasmid-borne CTX-M genes were selected for broth-mating experiments. Among the 20 isolates, 12 were found to be involved in conjugating plasmid-borne bla CTX-M resistance to E. coli AB1157 at the frequency of 10 5 . Further, the conjugated plasmids were amplified by multiplex PCR for the presence of CTX-M gene in each transconjugant. As expected, among the 12 positive isolates, 11 isolates were found to carry CTX-M group 1 gene and one isolate was found to carry group 9. The twelve isolates that were involved in transferability includes, eight E. coli, two K. pneumoniae, one each of P. aeruginosa and M. morganii.
DISCUSSION
The prevalence of CTX-M type ESBL producers has progressively increased throughout the health care settings though it may vary between geographical locations 
CONCLUSION
In conclusion, we had found out the dissemination of ESBL producers from various regions within Tamil Nadu, India. The study also characterized the bla CTX-M group-1 followed by group-9 β-lactamases in Gram-negative bacteria isolated from Tamil Nadu, while the prevalence of CTX-M-15 has been reported previously. The study could highlight the efficiency of clinical isolates to conjugate its plasmid-borne resistance. This finding may well explain the reason for the dissemination of resistance determinants within bacteria isolated from nosocomial infections. This study puts forward the importance of using cephalosporins more effectively considering the global scenario of antibiotic resistance.
